ETF Exchange > ARCX:SBIO ETF
ARCX:SBIO - ETF Fact Sheet
ALPS Medical Breakthroughs ETF - USD
Fund Identification
Ticker
ARCX:SBIO
ISIN
US00162Q5936
Main Metrics
Price
$66.66Expense Ratio
0.5%AuM
$239.98MTracking Difference
-0.00%Ratings
Trackinsight rating
★★★★★Official Investment Strategy
The ALPS Medical Breakthroughs ETF invests in the public equity markets of the United States. It invests in the stocks of companies operating in the biotechnology and pharmaceutical sectors. The fund invests in stocks of mid cap and small cap companies with a market capitalization of no less than $200 million and no more than $5 billion. It seeks to replicate the performance of the S-Network Medical Breakthroughs Index, by investing in the stocks of companies as per their weightings in the index.
ARCX:SBIO's historical prices, performance, and flows
1m returns
2.44%
1m flows
$29M
* Net total returns
All data as of 31 August 2026
The ETF Exchange is brought to you by
With data and analysis by
See all ARCX:SBIO data with a
free P&I Online account
free P&I Online account
Enjoy unlimited ETF searches and access to tear-sheets of over 4,000 North-American funds.
or Login
ARCX:SBIO's characteristics
Manager
Manager statistics
23 funds, $21.63Bn in AUM
Benchmark
S-Network Medical Breakthroughs Index NTR - USD
Replication method
Direct (Physical)
Asset class
Equity
Dividend policy
Distributing
ARCX:SBIO's exposure
Countries
USA
88.61%
Other
11.39%
Sectors
Healthcare
98.48%
Top 5 holdings
Crinetics Pharmaceuticals, Inc.
4.75%
Apogee Therapeutics, Inc.
4.48%
CG Oncology, Inc.
3.39%
Xenon Pharmaceuticals, Inc.
3.26%
Dianthus Therapeutics, Inc.
3.15%
Total holdings
102
Total weight of top 5
19.02%